Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Kieslich da Silva, Alexandre
Reche, Mateus
Lima, Ana Flávia da Silva
Fleck, Marcelo Pio de Almeida
Capp, Edison
and
Shansis, Flávio Milman
2019.
Assessment of the psychometric properties of the 17- and 6-item Hamilton Depression Rating Scales in major depressive disorder, bipolar depression and bipolar depression with mixed features.
Journal of Psychiatric Research,
Vol. 108,
Issue. ,
p.
84.
Sampogna, Gaia
Del Vecchio, Valeria
Giallonardo, Vincenzo
Luciano, Mario
and
Fiorillo, Andrea
2020.
Diagnosis, Clinical Features, and Therapeutic Implications of Agitated Depression.
Psychiatric Clinics of North America,
Vol. 43,
Issue. 1,
p.
47.
O'Donovan, Claire
and
Alda, Martin
2020.
Depression Preceding Diagnosis of Bipolar Disorder.
Frontiers in Psychiatry,
Vol. 11,
Issue. ,
Bartoli, Francesco
Crocamo, Cristina
and
Carrà, Giuseppe
2020.
Clinical correlates of DSM-5 mixed features in bipolar disorder: A meta-analysis.
Journal of Affective Disorders,
Vol. 276,
Issue. ,
p.
234.
Natale, Antimo
Mineo, Ludovico
Fusar-Poli, Laura
Aguglia, Andrea
Rodolico, Alessandro
Tusconi, Massimo
Amerio, Andrea
Serafini, Gianluca
Amore, Mario
and
Aguglia, Eugenio
2022.
Mixed Depression: A Mini-Review to Guide Clinical Practice and Future Research Developments.
Brain Sciences,
Vol. 12,
Issue. 1,
p.
92.
Tunc, Ece Buyuksandalyaci
and
Tunc, Serhat
2022.
Vortioxetine Induced Hypomania: A Case Presentation and Review of the Literature.
Clinical Psychopharmacology and Neuroscience,
Vol. 20,
Issue. 2,
p.
394.
Zimmerman, Mark
and
Mackin, Daniel
2023.
Identifying the DSM-5 mixed features specifier in depressed patients: A comparison of measures.
Journal of Affective Disorders,
Vol. 339,
Issue. ,
p.
854.
Zimmerman, Mark
and
Mackin, Daniel
2024.
Validity of the DSM‐5 Mixed Features Specifier Interview.
Bipolar Disorders,
Vol. 26,
Issue. 5,
p.
479.
Bartoli, Francesco
Cavaleri, Daniele
Riboldi, Ilaria
Callovini, Tommaso
Crocamo, Cristina
Gastaldon, Chiara
Aguglia, Andrea
Callegari, Camilla
Cavallotti, Simone
Chiappini, Stefania
Cruciata, Marco
D’Agostino, Armando
Espa, Irene
Grassi, Luigi
Ielmini, Marta
Mammarella, Silvia
Martinotti, Giovanni
Rania, Marianna
Rodolico, Alessandro
Roncone, Rita
Roselli, Valentina
Segura-Garcia, Cristina
Signorelli, Maria Salvina
Tarsitani, Lorenzo
Ostuzzi, Giovanni
and
Carrà, Giuseppe
2025.
Efficacy and Tolerability of Vortioxetine Versus Selective Serotonin Reuptake Inhibitors for Late-Life Depression: A Post-hoc Analysis of the VESPA Study.
Drugs & Aging,
Vol. 42,
Issue. 8,
p.
771.
Carmellini, Pietro
Cuomo, Alessandro
Pierini, Caterina
Pardossi, Simone
Pinzi, Mario
Mariantoni, Elisa
and
Fagiolini, Andrea
2025.
Intravenous trazodone for the treatment of psychomotor agitation and associated symptoms in major depressive disorder patients experiencing a depressive episode with mixed features.
International Clinical Psychopharmacology,
Pepe, Maria
Di Nicola, Marco
Mandracchia, Giuseppe
Margoni, Stella
Monacelli, Leonardo
Restaino, Antonio
Koukopoulos, Alexia Emilia
and
Sani, Gabriele
2025.
Physical symptoms and inflammatory levels characterize post-COVID-19 depressive episodes compared to non-post-COVID-19 depression.
Journal of Affective Disorders,
Vol. 383,
Issue. ,
p.
410.